Company intelligence / Profile preview

Habert Dassault Finance

Paris, Île-de-France, France

Ownership: Private
Employees: ~2
Development stage: Other

Overview

Habert Dassault Finance is a French private investment firm and venture capital investor based in Paris. It invests across technology and other growth sectors rather than operating as a drug developer, pharmaceutical company, or healthcare services provider. Public databases describe it as an active SAS entity founded in 1996, while investor databases characterize it as a seed-to-later-stage investment firm. Although it has invested in at least one health-related company, Remedee Labs, Habert Dassault Finance itself is not a life sciences or healthcare operating company.

Industry: Investors

Beyond the preview

Go deeper on Habert Dassault Finance.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Habert Dassault Finance.

Explore the full profile